Retraction Note to: Metabolic syndrome factors and risk of postoperative depression in high-grade glioma patients in a 1.5-year prospective study Jian-tong JiaoChen JiangJun-fei Shao Retraction Note 19 September 2017 Article: 181
Notch signaling pathway networks in cancer metastasis: a new target for cancer therapy Li LiPing TangYiyao Liu Review Article 16 September 2017 Article: 180
Genetic susceptibility in childhood acute lymphoblastic leukemia Angela Gutierrez-CaminoIdoia Martin-GuerreroAfrica García-Orad Review Article 13 September 2017 Article: 179
Theoretical method for evaluation of therapeutic effects and adverse effects of epidermal growth factor receptor tyrosine kinase inhibitors in clinical treatment Koji KimuraRisa TakayanagiYasuhiko Yamada Original Paper 08 September 2017 Article: 178
Pre-treatment carcinoembryonic antigen and outcome of patients with rectal cancer receiving neo-adjuvant chemo-radiation and surgical resection: a systematic review and meta-analysis Giuseppe CollocaAntonella VenturinoPasquale Vitucci Review Article 07 September 2017 Article: 177
Molecular modeling and structure-based drug discovery approach reveals protein kinases as off-targets for novel anticancer drug RH1 Pramodkumar P. GuptaVirupaksha A. BastikarMindaugas Valius Original Paper 06 September 2017 Article: 176
EGFR and KRAS mutations do not enrich for the activation of IL-6, JAK1 or phosphorylated STAT3 in resected lung adenocarcinoma Timothy D. ClayPrudence A. RussellMelissa M. Moore Original Paper 06 September 2017 Article: 175
Yttrium-90 radioembolization treatment for unresectable hepatocellular carcinoma: a single-centre prognostic factors analysis C. FloridiF. PesapaneG. Carrafiello Original Paper 05 September 2017 Article: 174
Personalized ex vivo multiple peptide enrichment and detection of T cells reactive to multiple tumor-associated antigens in prostate cancer patients Pavla TaborskaDmitry StakheevDaniel Smrz Original Paper 02 September 2017 Article: 173
Fluorescence in situ hybridization as prognostic predictor of tumor recurrence during treatment with Bacillus Calmette–Guérin therapy for intermediate- and high-risk non-muscle-invasive bladder cancer Esmee I. M. L. LiemJoyce BaardTheo M. de Reijke Original Paper Open access 02 September 2017 Article: 172
Induction of antitumor response to fibrosarcoma by Newcastle disease virus-infected tumor vaccine Mai Takamura-IshiiTakahiro MiuraKatsuro Hagiwara Original Paper Open access 01 September 2017 Article: 171
Checkpoint inhibitors: the new treatment paradigm for urothelial bladder cancer Heather KatzEmnet WassieMohamed Alsharedi Review Article 01 September 2017 Article: 170
Correlation of early PET findings with tumor response to molecular targeted agents in patients with advanced driver-mutated non-small cell lung cancer Tomonobu KoizumiToshirou FukushimaKazuhiro Oguchi Original Paper 01 September 2017 Article: 169
Interleukin-8 and nuclear factor kappa B are increased and positively correlated in myelodysplastic syndrome Anacélia Gomes de MatosHoward Lopes Ribeiro JuniorSilvia Maria Meira Magalhães Short Communication 30 August 2017 Article: 168
Clinical benefit of antiangiogenic therapy in advanced and metastatic chondrosarcoma Robin L. JonesDaniela KatzSeth M. Pollack Original Paper Open access 29 August 2017 Article: 167
Low dose versus standard dose of corticosteroids in the management of adverse events of special interest from abiraterone acetate: data from a literature-based meta-analysis Giandomenico RovielloSilvia Paola CoronaDaniele Generali Short Communication 29 August 2017 Article: 166
